These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21352258)

  • 81. Deciphering the molecular mechanism of enhanced tumor activity of the EGFR variant T790M/L858R using melanoma cell lines.
    Shao H; Wells A
    Front Oncol; 2023; 13():1163504. PubMed ID: 37333807
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Anticancer Effect of Cold Atmospheric Plasma in Syngeneic Mouse Models of Melanoma and Colon Cancer.
    Jung JM; Yoon HK; Kim SY; Yun MR; Kim GH; Lee WJ; Lee MW; Chang SE; Won CH
    Molecules; 2023 May; 28(10):. PubMed ID: 37241912
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The Cross Talk between Cellular Senescence and Melanoma: From Molecular Pathogenesis to Target Therapies.
    Liu J; Zheng R; Zhang Y; Jia S; He Y; Liu J
    Cancers (Basel); 2023 May; 15(9):. PubMed ID: 37174106
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Prognostic value of receptor tyrosine kinases in malignant melanoma patients: A systematic review and meta-analysis of immunohistochemistry.
    Lei X; Zhang Y; Mao L; Jiang P; Huang Y; Gu J; Tai N
    Front Oncol; 2022; 12():819051. PubMed ID: 36212475
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Gene Regulations upon Hydrogel-Mediated Drug Delivery Systems in Skin Cancers-An Overview.
    Mathiyalagan R; Kariyarath Valappil A; Yang DC; Kang SC; Thambi T
    Gels; 2022 Sep; 8(9):. PubMed ID: 36135270
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Effects of Para-Toluenesulfonamide on Canine Melanoma Xenotransplants in a BALB/c Nude Mouse Model.
    Lin CT; Lin CF; Wu JT; Tsai HP; Cheng SY; Liao HJ; Lin TC; Wu CH; Lin YC; Wang JH; Chang GR
    Animals (Basel); 2022 Sep; 12(17):. PubMed ID: 36077992
    [TBL] [Abstract][Full Text] [Related]  

  • 87. PO2RDF: representation of real-world data for precision oncology using resource description framework.
    Zhao Y; Dimou A; Shen F; Zong N; Davila JI; Liu H; Wang C
    BMC Med Genomics; 2022 Jul; 15(1):167. PubMed ID: 35907849
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Mechanistic Translation of Melanoma Genetic Landscape in Enriched Pathways and Oncogenic Protein-Protein Interactions.
    Massimino M; Stella S; Micale G; Motta L; Pavone G; Broggi G; Piombino E; Magro G; Soto Parra HJ; Manzella L; Vigneri P
    Cancer Genomics Proteomics; 2022; 19(3):350-361. PubMed ID: 35430568
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Extracellular Vesicles Derived from Acidified Metastatic Melanoma Cells Stimulate Growth, Migration, and Stemness of Normal Keratinocytes.
    Bychkov ML; Kirichenko AV; Mikhaylova IN; Paramonov AS; Yastremsky EV; Kirpichnikov MP; Shulepko MA; Lyukmanova EN
    Biomedicines; 2022 Mar; 10(3):. PubMed ID: 35327461
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Synthesis and characterization of a novel pH-responsive drug-releasing nanocomposite hydrogel for skin cancer therapy and wound healing.
    Gonsalves A; Tambe P; Le D; Thakore D; Wadajkar AS; Yang J; Nguyen KT; Menon JU
    J Mater Chem B; 2021 Dec; 9(46):9533-9546. PubMed ID: 34757371
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Ferroptosis-Associated Classifier and Indicator for Prognostic Prediction in Cutaneous Melanoma.
    Zeng H; You C; Zhao L; Wang J; Ye X; Yang T; Wan C; Deng L
    J Oncol; 2021; 2021():3658196. PubMed ID: 34745259
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Prognostic Significance of Epidermal Growth Factor Receptor Expression in Distant Metastatic Melanoma from Primary Cutaneous Melanoma.
    Lee KH; Suh HY; Lee MW; Lee WJ; Chang SE
    Ann Dermatol; 2021 Oct; 33(5):432-439. PubMed ID: 34616124
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Proof-of-Concept Study of Multifunctional Hybrid Nanoparticle System Combined with NIR Laser Irradiation for the Treatment of Melanoma.
    Lopes J; Ferreira-Gonçalves T; Figueiredo IV; Rodrigues CMP; Ferreira H; Ferreira D; Viana AS; Faísca P; Gaspar MM; Coelho JMP; Silva CO; Reis CP
    Biomolecules; 2021 Mar; 11(4):. PubMed ID: 33808293
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Molecular targets for anticancer therapies in companion animals and humans: what can we learn from each other?
    Beltrán Hernández I; Kromhout JZ; Teske E; Hennink WE; van Nimwegen SA; Oliveira S
    Theranostics; 2021; 11(8):3882-3897. PubMed ID: 33664868
    [TBL] [Abstract][Full Text] [Related]  

  • 95. ST3GAL1 is a target of the SOX2-GLI1 transcriptional complex and promotes melanoma metastasis through AXL.
    Pietrobono S; Anichini G; Sala C; Manetti F; Almada LL; Pepe S; Carr RM; Paradise BD; Sarkaria JN; Davila JI; Tofani L; Battisti I; Arrigoni G; Ying L; Zhang C; Li H; Meves A; Fernandez-Zapico ME; Stecca B
    Nat Commun; 2020 Nov; 11(1):5865. PubMed ID: 33203881
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Cancer cell line-specific protein profiles in extracellular vesicles identified by proteomics.
    Guerreiro EM; Øvstebø R; Thiede B; Costea DE; Søland TM; Kanli Galtung H
    PLoS One; 2020; 15(9):e0238591. PubMed ID: 32886718
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Ellagic acid inhibits cell proliferation, migration, and invasion in melanoma via EGFR pathway.
    Wang F; Chen J; Xiang D; Lian X; Wu C; Quan J
    Am J Transl Res; 2020; 12(5):2295-2304. PubMed ID: 32509220
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Diverse roles of epidermal growth factors receptors in oral and cutaneous canine melanomas.
    Veloso ES; Gonçalves INN; Silveira TL; Oliveira FS; Vieira DS; Cassali GD; Del Puerto HL; Ferreira E
    BMC Vet Res; 2020 Jan; 16(1):24. PubMed ID: 31996230
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Dissecting Mechanisms of Melanoma Resistance to BRAF and MEK Inhibitors Revealed Genetic and Non-Genetic Patient- and Drug-Specific Alterations and Remarkable Phenotypic Plasticity.
    Hartman ML; Sztiller-Sikorska M; Gajos-Michniewicz A; Czyz M
    Cells; 2020 Jan; 9(1):. PubMed ID: 31936151
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Combination of Selected MET and EGFR Inhibitors Decreases Melanoma Cells' Invasive Abilities.
    Simiczyjew A; Pietraszek-Gremplewicz K; Dratkiewicz E; Podgórska M; Matkowski R; Ziętek M; Nowak D
    Front Pharmacol; 2019; 10():1116. PubMed ID: 31649529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.